2026 NPPES data Cardiovascular Disease Physician NPI 1275558330 M.D.
Verify on CMS →

JOSEPH GHAZAL, M.D.

Cardiovascular Disease Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 335 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
13.5672/100
▼ 70 pts below national avg 83.1 · [object Object]
Industry payments
$460.58
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JOSEPH GHAZAL, M.D. reported a CMS MIPS final score of 13.5672/100 — below the 83.1 national average — and filed 1,389 Medicare Part D claims in 2023.

13.5672/100
MIPS score · -70 vs avg
1K
Part D claims, 2023
78%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOSEPH GHAZAL, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

14 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). This entry sits in this band. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JOSEPH GHAZAL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOSEPH GHAZAL, M.D.?

Below national average

NPI registry status

Active

Issued 07/12/2006

NPI 1275558330

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

1,389 54% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

MIPS final score

13.5672/100 69.5328% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in California

How Cardiovascular Disease Physician compares to other specialties among California providers

California providers

Cardiovascular Disease Physician share within California

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within California

Medicare quality performance — MIPS

JOSEPH GHAZAL, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average

Below national average
MIPS Final Score
13.5672/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cardiovascular Disease Physician) — 13.5672/100 vs national avg 83.1

0%100%National avg83%13.6%
MIPS final score (Cardiovascular Disease Physician) — 13.5672/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOSEPH GHAZAL, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 1300 N VERMONT AVE, LOS ANGELES, CA, 90027, with a listed phone of (323) 913-4303. NPI 1275558330 was issued on 07/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GHAZAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,389 prescription claims written by this provider, covering 335 Medicare beneficiaries and totaling roughly $432K in drug spend, split 22% brand-name and 78% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 13.5672/100 for the 2023 performance year (Quality 0, Cost 45.224), compared with the national average of 83.1.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1300 N VERMONT AVE
LOS ANGELES, CA 90027

Provider Details

NPI 1275558330
Specialty Cardiovascular Disease Physician
Credentials M.D.
Gender Male
NPI Issued 07/12/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

13.5672
Final Score
Avg: 83.1
0
Quality
45.224
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where JOSEPH GHAZAL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COMPLETE CARE COMMUNITY HEALTH CENTER, INC
LOS ANGELES, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOSEPH GHAZAL, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$461

Largest payer

ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JOSEPH GHAZAL, M.D.. To verify JOSEPH GHAZAL, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JOSEPH GHAZAL, M.D. — brand share 22.0%
Specialty average (est.)

22% brand-name claims vs 78% generic, on 1,389 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,389
Total Claims
$432K
Total Drug Cost
335
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,374
Total Day Supply
100,755
Brand vs Generic
22% brand / 78% generic
Brand Drug Cost
$399K
Generic Drug Cost
$33K

Patient Demographics

Average Patient Age
70.5 years
Avg HCC Risk Score
1.65
Gender Split
53% female / 47% male
Age Distribution
<65: 44, 65-74: 215, 75-84: 57, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOSEPH GHAZAL, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Metoprolol Succinate
171
Atorvastatin Calcium
146
Lisinopril
102
Amlodipine Besylate
82
Losartan Potassium
72
Eliquis
Apixaban
71
Entresto
Sacubitril/Valsartan
62
Nitroglycerin
57
Jardiance
Empagliflozin
56
Carvedilol
55

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How JOSEPH GHAZAL, M.D. fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

JOSEPH GHAZAL, M.D.'s 1,389 claims are below the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GHAZAL.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOSEPH GHAZAL, M.D.'s specialty?
JOSEPH GHAZAL, M.D. specializes in Cardiovascular Disease Physician and practices in LOS ANGELES, California. Credentials: M.D..
How much does JOSEPH GHAZAL, M.D. prescribe under Medicare Part D?
In 2023, JOSEPH GHAZAL, M.D. wrote 1,389 Medicare Part D claims totaling $432K in drug costs for 335 beneficiaries.
What is JOSEPH GHAZAL, M.D.'s Medicare quality score?
JOSEPH GHAZAL, M.D. has a CMS MIPS Final Score of 13.5672/100 (Quality: 0, Cost: 45.224). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JOSEPH GHAZAL, M.D. located?
JOSEPH GHAZAL, M.D. is located at 1300 N VERMONT AVE, LOS ANGELES, CA, 90027. Phone: (323) 913-4303.
What is JOSEPH GHAZAL, M.D.'s NPI number?
JOSEPH GHAZAL, M.D.'s National Provider Identifier (NPI) is 1275558330, issued on 07/12/2006.
Does JOSEPH GHAZAL, M.D. prescribe more brand-name or generic drugs?
JOSEPH GHAZAL, M.D.'s prescribing is 22% brand-name and 78% generic drugs by claim count, with $399K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does JOSEPH GHAZAL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOSEPH GHAZAL, M.D.'s most frequently prescribed drugs include Metoprolol Succinate, Atorvastatin Calcium, Lisinopril. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOSEPH GHAZAL, M.D. accept Medicare?
JOSEPH GHAZAL, M.D. appears in CMS Medicare data with 1,389 Part D claims and 335 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOSEPH GHAZAL, M.D.'s credentials?
JOSEPH GHAZAL, M.D.'s NPI is 1275558330 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology